Matrix metalloproteinase inhibitor for the treatment of ALS
Ended Project Grant Awarded Last action
- Award ID
- W81XWH2210574
- Recipient
-
Aquilus Pharmaceuticals, Inc. UEI EM9ULMXK5F21
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $1,922,300
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date
- Originally
- Funding
-
- $961,150.00 Federal
- $961,150.00 Non-federal
- Place of performance
- Winchester, MA 01890, USA
Award details come from USAspending.gov.
Transactions
| Action | Federal | Non-federal | Date |
|---|---|---|---|
| Amendment | $0 | $0 | |
| Original award | $961,150 | $961,150 |
Quick answers
Who received award W81XWH2210574?
W81XWH2210574 was awarded to Aquilus Pharmaceuticals, Inc. by Defense Health Agency (Department of Defense) on June 15, 2022.
How much is award W81XWH2210574 worth?
$1,922,300 has been obligated on W81XWH2210574: $961,150 in federal funding and $961,150 in non-federal funding.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award